Harbor Investment Advisory LLC boosted its stake in Leidos Holdings, Inc. (NYSE:LDOS - Free Report) by 3,500.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,520 shares of the aerospace company's stock after purchasing an additional 2,450 shares during the quarter. Harbor Investment Advisory LLC's holdings in Leidos were worth $363,000 as of its most recent SEC filing.
Several other institutional investors have also recently made changes to their positions in LDOS. State Street Corp grew its stake in shares of Leidos by 1.0% in the 3rd quarter. State Street Corp now owns 5,800,357 shares of the aerospace company's stock valued at $945,458,000 after buying an additional 56,066 shares during the period. JPMorgan Chase & Co. grew its stake in Leidos by 13.1% in the third quarter. JPMorgan Chase & Co. now owns 3,504,392 shares of the aerospace company's stock valued at $571,216,000 after acquiring an additional 405,256 shares during the period. Geode Capital Management LLC increased its holdings in shares of Leidos by 1.3% during the third quarter. Geode Capital Management LLC now owns 3,365,903 shares of the aerospace company's stock valued at $546,912,000 after acquiring an additional 42,358 shares in the last quarter. FMR LLC raised its position in shares of Leidos by 27.8% during the third quarter. FMR LLC now owns 2,405,726 shares of the aerospace company's stock worth $392,133,000 after purchasing an additional 522,764 shares during the period. Finally, Massachusetts Financial Services Co. MA raised its position in shares of Leidos by 2.5% during the third quarter. Massachusetts Financial Services Co. MA now owns 2,153,420 shares of the aerospace company's stock worth $351,007,000 after purchasing an additional 53,307 shares during the period. Institutional investors and hedge funds own 76.12% of the company's stock.
A number of analysts have commented on the stock. Barclays boosted their price target on shares of Leidos from $165.00 to $210.00 and gave the company an "overweight" rating in a research note on Monday, November 4th. Citigroup upped their target price on shares of Leidos from $194.00 to $220.00 and gave the stock a "buy" rating in a report on Wednesday, October 30th. Wells Fargo & Company cut their price target on Leidos from $205.00 to $199.00 and set an "overweight" rating for the company in a research note on Wednesday, January 8th. The Goldman Sachs Group downgraded Leidos from a "buy" rating to a "neutral" rating and lowered their price objective for the stock from $228.00 to $153.00 in a research note on Thursday, December 12th. Finally, UBS Group started coverage on Leidos in a research report on Monday, December 2nd. They set a "neutral" rating and a $182.00 target price on the stock. Five analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Leidos currently has a consensus rating of "Moderate Buy" and a consensus target price of $179.07.
View Our Latest Stock Analysis on LDOS
In related news, Director Noel B. Geer bought 2,000 shares of the business's stock in a transaction on Wednesday, November 20th. The stock was acquired at an average price of $161.13 per share, for a total transaction of $322,260.00. Following the purchase, the director now directly owns 2,000 shares in the company, valued at $322,260. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Surya N. Mohapatra sold 2,748 shares of the company's stock in a transaction dated Thursday, November 7th. The shares were sold at an average price of $194.97, for a total value of $535,777.56. Following the sale, the director now owns 20,001 shares in the company, valued at approximately $3,899,594.97. This represents a 12.08 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.96% of the stock is currently owned by corporate insiders.
NYSE:LDOS opened at $160.60 on Wednesday. The firm's 50 day moving average is $156.10 and its 200 day moving average is $158.16. Leidos Holdings, Inc. has a 12 month low of $108.95 and a 12 month high of $202.90. The stock has a market capitalization of $21.43 billion, a PE ratio of 18.29, a price-to-earnings-growth ratio of 1.02 and a beta of 0.66. The company has a current ratio of 1.23, a quick ratio of 1.15 and a debt-to-equity ratio of 0.87.
Leidos (NYSE:LDOS - Get Free Report) last issued its quarterly earnings results on Tuesday, October 29th. The aerospace company reported $2.93 EPS for the quarter, beating analysts' consensus estimates of $1.96 by $0.97. Leidos had a return on equity of 30.31% and a net margin of 7.37%. The firm had revenue of $4.19 billion for the quarter, compared to analysts' expectations of $4.06 billion. During the same quarter in the prior year, the firm earned $2.03 EPS. The business's revenue for the quarter was up 6.9% compared to the same quarter last year. Sell-side analysts expect that Leidos Holdings, Inc. will post 10.03 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 31st. Stockholders of record on Monday, December 16th were given a $0.40 dividend. The ex-dividend date was Monday, December 16th. This represents a $1.60 annualized dividend and a dividend yield of 1.00%. This is a positive change from Leidos's previous quarterly dividend of $0.38. Leidos's payout ratio is 18.22%.
Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Leidos, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Leidos wasn't on the list.
While Leidos currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.